Remove 2030 Remove Leads Remove Sales
article thumbnail

With Novo Nordisk, Eli Lilly and AstraZeneca leading the way, Big Pharma's sales will grow 4% annually through 2030: analysts

Fierce Pharma

With Novo Nordisk, Eli Lilly and AstraZeneca leading the way, Big Pharma's sales will grow 4% annually through 2030: analysts kdunleavy Mon, 10/02/2023 - 15:19

Leads 173
article thumbnail

2022 Sales Hiring Forecast

Sales Talent

At the beginning of each year, we compile our sales hiring forecast by looking at the overall hiring forecasts for the year made by Manpower, Glassdoor, Indeed, Monster, and the Bureau of Labor & Statistics (BLS). 2021 Sales Hiring in Review. 2021 Sales Hiring in Review. 2022 Sales Forecast for Hiring.

Sales 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Endometriosis market projected to grow at a CAGR of 10% between 2020 and 2030

Pharmaceutical Technology

The endometriosis market is expected to grow from $1.05bn in 2020 to $2.72bn in 2030 at a compound annual growth rate (CAGR) of 10.0% The figure below summarises the endometriosis market growth across the 7MM from 2020 to 2030. At the end of 2030, the US will contribute approximately 81.3% of 7MM sales.

article thumbnail

Eli Lilly achieving significant gains in obesity results

Pharmaceutical Technology

Eli Lilly has achieved significant gains in the past quarter, leading to it becoming the most valuable pharmaceutical company in the world, with a market cap of $420bn, surpassing Johnson & Johnson. There have been several Phase III trials for Mounjaro, with SURMOUNT-1 demonstrating a weight loss of up to 22.5%

Leads 98
article thumbnail

CD19 CAR-T agents to boost blood cancer market

European Pharmaceutical Review

GlobalData predicts Bristol-Myers Squibb’s Breyanzi and Gilead’s Yescarta are set to have high annual sales in the forecast period. Yescarta for blood cancer Yescarta is targeting expansions into the first line for diffuse large B-cell lymphoma (DLBCL) and second line for follicular lymphoma in 2030. billion in 2031.

article thumbnail

France gets new sterile liquid drug manufacturing facility

European Pharmaceutical Review

billion by 2030 The post France gets new sterile liquid drug manufacturing facility appeared first on European Pharmaceutical Review. The 9,500m 2 facility will harness state-of-the-art containment technologies, Baduel confirmed. HPAPI contract manufacturing to value $14.6

article thumbnail

Guide to Hiring a Sales Manager

Quantified

Without a successful sales team , an organization can’t thrive. The sales team turns leads into customers, guiding prospects through their concerns until they arrive at the sale. That leads to another question: how do you identify and hire the best sales manager for your organization?